SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Shares
Shares outstanding: 71,858,757
Number of holders: 16
Total 13F shares, excl. options: 11,809,394
Shares change: -56,769
Total reported value, excl. options: $74,647,000
Value change: -$363,749
Number of sells: -8
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2019

20 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2019.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,809,394 shares of 71,858,757 outstanding shares and own 16.43% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5,900,000 shares), ORBIMED ADVISORS LLC (2,839,500 shares), RENAISSANCE TECHNOLOGIES LLC (2,375,841 shares), Neumann Advisory Hong Kong Ltd (315,586 shares), STATE STREET CORP (160,875 shares), Yorktown Management & Research Co Inc (74,893 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68,732 shares), GEODE CAPITAL MANAGEMENT, LLC (27,717 shares), Eqis Capital Management, Inc. (20,759 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,430 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.